We are live on ! Find out more
GIP

Greatmark Investment Partners Portfolio holdings

AUM $906M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.67%
AUM
$553M
AUM Growth
+$41M
Cap. Flow
+$5.74M
Cap. Flow %
1.04%
Top 10 Hldgs %
40.16%
Holding
140
New
5
Increased
35
Reduced
50
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 21.26%
2 Financials 18.33%
3 Industrials 12.06%
4 Healthcare 11.62%
5 Consumer Discretionary 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
26
Zebra Technologies
ZBRA
$17.8B
$8.11M 1.47%
15,325
-795
-5% -$396K
PYPL icon
27
PayPal
PYPL
$50.5B
$7.37M 1.33%
25,270
-935
-4% -$247K
ELV icon
28
Elevance Health
ELV
$85.5B
$7.19M 1.3%
18,826
-425
-2% -$162K
DISCK
29
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$7.15M 1.29%
+246,842
New +$7.67M
ABBV icon
30
AbbVie
ABBV
$435B
$5.94M 1.07%
52,753
-425
-0.8% -$47.9K
EMR icon
31
Emerson Electric
EMR
$88.3B
$5.62M 1.02%
58,423
-265
-0.5% -$24.9K
TRV icon
32
Travelers Companies
TRV
$80.2B
$3.95M 0.71%
26,371
+12,831
+95% +$1.99M
JPS
33
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$3.74M 0.68%
375,892
-7,983
-2% -$78.6K
LDP icon
34
Cohen & Steers Duration Preferred & Income Fund
LDP
$600M
$3.6M 0.65%
131,237
+11,250
+9% +$300K
GD icon
35
General Dynamics
GD
$106B
$3.55M 0.64%
18,837
+375
+2% +$70.7K
MCD icon
36
McDonald's
MCD
$195B
$3.54M 0.64%
15,321
+3
+0% +$698
CHY
37
Calamos Convertible and High Income Fund
CHY
$1.06B
$3.5M 0.63%
214,296
-1,019
-0.5% -$16.1K
NKG
38
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$3.32M 0.6%
237,039
-8,750
-4% -$119K
BIIB icon
39
Biogen
BIIB
$30.7B
$3.16M 0.57%
9,125
+2,780
+44% +$842K
AMLP icon
40
Alerian MLP ETF
AMLP
$12.8B
$3.04M 0.55%
83,375
+6,925
+9% +$238K
WHR icon
41
Whirlpool
WHR
$2.82B
$2.84M 0.51%
13,029
-315
-2% -$73.4K
PDS
42
Precision Drilling
PDS
$974M
$2.79M 0.51%
67,012
+12,375
+23% +$385K
GIS icon
43
General Mills
GIS
$19.7B
$2.52M 0.46%
41,342
OXY icon
44
Occidental Petroleum
OXY
$55.9B
$2.48M 0.45%
79,400
-9,145
-10% -$245K
SO icon
45
Southern Company
SO
$107B
$2.45M 0.44%
40,425
+202
+0.5% +$12.9K
WMT icon
46
Walmart Inc
WMT
$890B
$2.31M 0.42%
49,080
-2,595
-5% -$121K
CVX icon
47
Chevron
CVX
$366B
$2.26M 0.41%
21,580
+525
+2% +$55.4K
TOTL icon
48
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
$2.2M 0.4%
45,414
MINT icon
49
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$2.17M 0.39%
21,300
-5,770
-21% -$588K
COHR
50
DELISTED
Coherent Inc
COHR
$2.16M 0.39%
8,165
-28,680
-78% -$7.54M

Similar funds

Greatmark Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Greatmark Investment Partners held 140 positions worth $553M, up 8% from $512M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Greatmark Investment Partners's Q2 2021 filing shows 5 new, 35 increased, 50 reduced and 3 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 246,842 shares worth $7.15M. The largest sale was Coherent Inc, an estimated $7.54M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

  • Greatmark Investment Partners's largest Q2 2021 buy was Discovery, Inc. Series C Common Stock: 246,842 shares worth $7.15M.
  • Greatmark Investment Partners added most to Amgen in Q2 2021, an estimated $5.5M increase.
  • Greatmark Investment Partners's biggest Q2 2021 reduction was Coherent Inc, cutting an estimated $7.54M.
  • Greatmark Investment Partners fully exited Novartis in Q2 2021, selling an estimated $1.69M.
  • Greatmark Investment Partners's ten largest holdings make up 40% of its $553M portfolio in Q2 2021.
  • Greatmark Investment Partners opened 5 new positions and closed 3 in Q2 2021.
  • Greatmark Investment Partners's portfolio value rose 8% quarter-over-quarter to $553M.

Based on Greatmark Investment Partners's 13F filing for Q2 2021, filed 23 Aug 2021.